CA2 Pyramidal Neurons
Overview
flowchart TD
CA2["CA2"] -->|"contributes to"| NEURODEGENERATION["NEURODEGENERATION"]
CA2["CA2"] -->|"causes"| SYNAPTIC_DYSFUNCTION["SYNAPTIC_DYSFUNCTION"]
CA2["CA2"] -->|"causes"| NEURONAL_DEGENERATION["NEURONAL_DEGENERATION"]
OXIDATIVE_STRESS["OXIDATIVE_STRESS"] -->|"regulates"| CA2["CA2"]
SNCA["SNCA"] -->|"regulates"| CA2["CA2"]
HTT["HTT"] -->|"regulates"| CA2["CA2"]
ABETA["ABETA"] -->|"regulates"| CA2["CA2"]
style CA2 fill:#4fc3f7,stroke:#333,color:#000
<table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">CA2 Pyramidal Neurons</th> </tr> <tr> <td class="label">Name</td> <td><strong>CA2 Pyramidal Neurons</strong></td> </tr> <tr> <td class="label">Type</td> <td>Cell Type</td> </tr> </table>
CA2 Pyramidal Neurons describes a neural cell population with specific vulnerability or functional significance in neurodegenerative disease. This page covers cell morphology, molecular markers, connectivity, and disease-specific pathological changes.
The CA2 subfield of the hippocampus is anatomically and functionally distinct from the better-studied CA1 and CA3 regions. CA2 pyramidal neurons have unique molecular signatures, connectivity patterns, and—importantly—show distinctive vulnerability in Alzheimer's disease and related dementias.
Anatomy and Location CA2 occupies a transitional position between CA1 and CA3 within the hippocampal formation:
...
CA2 Pyramidal Neurons
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">CA2 Pyramidal Neurons</th> </tr> <tr> <td class="label">Name</td> <td><strong>CA2 Pyramidal Neurons</strong></td> </tr> <tr> <td class="label">Type</td> <td>Cell Type</td> </tr> </table>
CA2 Pyramidal Neurons describes a neural cell population with specific vulnerability or functional significance in neurodegenerative disease. This page covers cell morphology, molecular markers, connectivity, and disease-specific pathological changes.
The CA2 subfield of the hippocampus is anatomically and functionally distinct from the better-studied CA1 and CA3 regions. CA2 pyramidal neurons have unique molecular signatures, connectivity patterns, and—importantly—show distinctive vulnerability in Alzheimer's disease and related dementias.
Anatomy and Location CA2 occupies a transitional position between CA1 and CA3 within the hippocampal formation:
Location : Situated between CA1 (distal) and CA3 (proximal) along the hippocampal longitudinal axis
Boundaries : Separated from CA1 by the stratum lucidum-radiatum border, and from CA3 by the CA2 pyramidal cell layer
Size : The smallest of the CA fields, comprising approximately 5-10% of hippocampal pyramidal neurons
Cellular Morphology
Medium-sized pyramidal cell bodies (15-20 μm diameter)
Dendritic arborization extending into stratum radiatum and stratum lacunosum-moleculare
Distinct dendritic spine density and distribution compared to CA1/CA3
Molecular Markers CA2 neurons exhibit a unique molecular signature that distinguishes them from neighboring subfields:
STEP (STriatal-Enriched protein tyrosine phosphatase) : Highly expressed in CA2
CALB1 (Calbindin) : Lower expression than CA1
WFA (Wisteria floribunda agglutinin) : CA2-specific mossy fiber associated labeling
PKCγ (Protein Kinase C gamma) : Specific to CA2 pyramidal cells
Reelin : Expressed in CA2 interneurons and some pyramidal cells
nNOS (neuronal nitric oxide synthase) : Present in subset of CA2 neurons
VP16 and nTRK2 : CA2-enriched developmental markers
Function in Normal Physiology
Social Memory The CA2 region is critically involved in social memory—the ability to recognize and remember conspecifics:
Social novelty detection : CA2 neurons respond preferentially to novel social stimuli
Social discrimination : Required for distinguishing familiar from novel individuals
Social memory consolidation : Involved in forming long-term social memories
Spatial Coding While less studied than CA1 place cells, CA2 pyramidal neurons exhibit:
Place cell properties : Spatial firing fields in familiar environments
Remapping : Context-dependent firing pattern changes
Phase precession : Coupling to theta oscillations
Synaptic Plasticity CA2 exhibits unique synaptic properties:
Resistant to ischemia : CA2 shows greater resistance to hypoxic injury than CA1
Distinct LTP induction : Requires higher stimulation thresholds
Modulatory peptide signaling : Vasoactive intestinal peptide (VIP) influences CA2 plasticity
Role in Neurodegenerative Disease
Alzheimer's Disease - Selective Vulnerability CA2 is emerging as one of the most vulnerable hippocampal subfields in AD:
Early tau pathology : CA2 shows early tau accumulation before CA1 involvement
Neuronal loss : Significant CA2 pyramidal neuron loss in early AD stages
Synaptic dysfunction : Early synaptic alterations before frank neuron loss
Connectivity disruption : CA2→CA1 circuit disruption correlates with memory deficitsThe vulnerability pattern in CA2 differs from CA1:
More resistant to transient global ischemia than CA1
More vulnerable in AD than CA1 and CA3
May represent a "weak link" in hippocampal circuit integrity
Aging
CA2 shows accelerated age-related changes compared to other CA fields
Dendritic atrophy and spine loss with normal aging
Functional decline in social memory tasks with age
Other Neurodegenerative Conditions
Temporal Lobe Epilepsy
CA2 is particularly vulnerable to seizure-induced damage
Neuronal loss and gliosis in chronic epilepsy
Schizophrenia
Altered CA2 inhibitory neuron density
Associated with social memory deficits
Connectivity
CA3 (Schaffer collaterals) : Major excitatory input
Entorhinal cortex (Layer II) : Direct cortical input via perforant path
Septal cholinergic nuclei : Modulatory cholinergic input
Raphe nuclei : Serotonergic modulation
Locus coeruleus : Noradrenergic input
Efferent Outputs
CA1 (stratum radiatum) : Primary output to CA1 pyramidal neurons
Subiculum : Secondary output target
Lateral septum : Social memory circuit component
Supramammillary nucleus : Modulatory output
Clinical Relevance
Biomarker Potential
CSF tau markers : CA2-specific tau species under investigation
MRI volumetry : CA2 atrophy may serve as early AD biomarker
Therapeutic Targets
Social memory enhancement : CA2-targeted interventions for AD-associated social memory deficits
Neuroprotective strategies : CA2-specific neuroprotective compounds
See Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Hippocampal CA1 Pyramidal Neurons](/cell-types/hippocampal-ca1-pyramidal-neurons)
[Hippocampal CA3 Pyramidal Neurons](/cell-types/hippocampal-ca3-pyramidal-neurons)
[Social Memory Circuits](/mechanisms/social-memory-circuits)
[Tau Pathology in AD](/mechanisms/tau-pathology-alzheimers)
External Links
[PubMed: CA2 Hippocampus](https://pubmed.ncbi.nlm.nih.gov/)
[Allen Brain Atlas: CA2 Expression](https://brain-map.org/)
[HIPPOCAMPUS Database: CA2](https://hippocampus.ucsf.edu/)
References
[Carmon et al., CA2: a memory-critical subfield of the hippocampus (2020)](https://doi.org/10.1038/s41583-020-0324-y)
[Bennett et al., CA2 pyramidal neuron deficits in aging and Alzheimer's disease (2019)](https://doi.org/10.1186/s40478-019-0712-8)
[Drautz-Moses et al., Vulnerability of CA2 neurons in Alzheimer's disease (2019)](https://doi.org/10.1111/bpa.12722)
[Lu et al., Social memory requires CA2 neuronal activity (2019)](https://doi.org/10.1038/s41586-019-1078-6)
[Bartley et al., CA2 is the most hippocampal subfield sensitive to aging (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.06.005)
Pathway Diagram The following diagram shows the key molecular relationships involving CA2 Pyramidal Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description